NCT02677844View on ClinicalTrials.gov

A Study of Abemaciclib in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions
Healthy
Interventions
DRUG

Abemaciclib

Administered orally

DRUG

Placebo

Administered orally

DRUG

Loperamide

Administered orally

Trial Locations (2)

32117

Covance Clinical Research Unit, Daytona Beach

47710

Covance Clinical Research Unit, Evansville

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT02677844 - A Study of Abemaciclib in Healthy Participants | Biotech Hunter | Biotech Hunter